Anavex Life Sciences Corp (AVXL)

[powerwalker]

abe, there are more than 50% of the P2b/3 participants in Australia. The first 225 were there before any expansion of the trial into other countries. I'm sure the Aussies did not stop recruiting after the first 225 were enrolled.

As to the R&D Day, June 21 was selected for a purpose. The first thought is related to the last trial participant in that trial is receiving her/his last dose this week. Second thought is that Anavex and TGD are ready to disclose the biomarker connections blarcamesine has shown between the 3 diseases and how efficacy is tied together.

For me, it will be very disappointing if R&D Day isn't a strong statement on the potency of the Anavex pipeline. Otherwise, why have it ... especially, when no one expected it? There has to be a very positive presentation.

As to PR's, Clint should not be involved until TGD is ready to reveal what is behind the curtain ("loose lips sink ships"). IMO, first PR in a day or two, states last dose for last participant with R&D Day details the following day. Meeting will be in NYC, if one wants to travel to it (no other place makes sense given our perceived audience is BP, MSM and competitors).

Regardless, this event is happening because TGD wants to share the value of the Anavex pipeline with the world. [I've been on pins & needles for the last two weeks!]

ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!